Immunoproteomics of Helicobacter pylori infection in patients with atrophic body gastritis, a predisposing condition for gastric cancer

International Journal of Medical Microbiology

Volumn 301, Issue 2, 2011, Pages 125-132

  Lahner, Edith ^a   Bernardini, Giulia ^b   Possenti, Silvia ^b   Renzone, Giovanni ^c   Scaloni, Andrea ^c   Santucci, Annalisa ^b   Annibale, Bruno ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c CNR   (Italy)

Author keywords

Atrophic body gastritis; Gastric cancer; Helicobacter pylori; Immunoproteomics; Proteomics

Indexed keywords

BACTERIAL ANTIGEN;

ARTICLE; ATROPHIC GASTRITIS; BACTERIAL STRAIN; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIC ULCER; PROTEOMICS; STOMACH CANCER;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; ATROPHY; BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH;

EID: 78751581748     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2010.06.006     Document Type: Article

References (37)

1. Annibale B., Aprile M.R., D'Ambra G., Caruana P., Bordi C., Delle Fave G. Cure of Helicobacter pylori infection in atrophic body gastritis patients does not improve mucosal atrophy but reduces hypergastrinemia and its related effects on body ECL-cell hyperplasia. Aliment. Pharmacol. Ther. 2000, 14:625-634.
2. Atherton J.C., Blaser M.J. Coadaptation of Helicobacter pylori and humans: ancient history, modern implication. J. Clin. Invest. 2009, 119:2475-2487.
3. Bernardini G., Braconi D., Lusini P., Santucci A. Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev. Proteomics 2007, 4:679-689.
4. Bernardini G., Renzone G., Comanducci M., Mini R., Arena S., D'Ambrosio C., Bambini S., Trabalzini L., Grandi G., Martelli P., Achtman M., Scaloni A., Ratti G., Santucci A. Proteome analysis of Neisseria meningitidis serogroup A. Proteomics 2004, 4:2893-2926.
5. Cappell M.S., Friedel D. Acute nonvariceal upper gastrointestinal bleeding: endoscopic diagnosis and therapy. Med. Clin. North Am. 2008, 92:511-550.
6. Correa P. Helicobacter pylori and gastric carcinogenesis. Am. J. Surg. Pathol. 1995, 19(Suppl.):S37-S43.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res. 1992, 52:673-675.
8. Graham D.Y. Helicobacter pylori infection is the primary cause of gastric cancer. J. Gastroenterol. 2000, 35(Suppl. 12):90-97.
9. Haas G., Karaali G., Ebermayer K., Metzger W.G., Lamer S., Zimny-Arndt U., Diescher S., Goebel U.B., Vogt K., Roznowski A.B., Wiedenmann B.J., Meyer T.F., Aebischer T., Jungblut P.R. Immunoproteomics of Helicobacter pylori and relation to gastric disease. Proteomics 2002, 2:313-324.
10. Haber M.M. Histologic precursors of gastrointestinal tract malignancy. Gastroenterol. Clin. North Am. 2002, 31:395-419.
11. Hansson L.-E., Nyren O., Hsing A.W., Bergström R., Josefsson S., Chow W.H., Fraumeni J.F., Adami H.O. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N. Engl. J. Med. 1996, 335:242-249.
12. Jungblut P.R., Bumann D., Haas D., Zimny-Arndt U., Holland P., Lamer S., Siejak F., Aebischer A., Meyer T.F. Comparative proteome analysis of Helicobacter pylori. Mol. Microbiol. 2000, 36:710-725.
13. Kabir S. The current status of Helicobacter pylori vaccines: a review. Helicobacter 2007, 12:89-102.
14. Kimmel B., Bosserhoff A., Frank R., Gross R., Goebel W., Beier D. Identification of immunodominant antigens from Helicobacter pylori and evaluation of their reactivities with sera from patients with different gastroduodenal pathologies. Infect. Immun. 2000, 68:915-920.
15. Krah A., Miehlke S., Pleissner K.-P., Zimny-Arndt U., Kirsch C., Lehn N., Meyer T.F., Jungblut P.R., Aebischer T. Identification of candidate antigens for serologic detection of Helicobacter pylori-infection patients with gastric carcinoma. Int. J. Cancer 2004, 108:456-463.
16. Lin Y.F., Chen C.Y., Tsai M.H., Wu M.S., Wang Y.C., Chuang E.Y., Lin J.T., Yang P.C., Chow L.P. Duodenal ulcer-related antigens from Helicobacter pylori: immunoproteome and protein microarray approaches. Mol. Cell. Proteomics 2007, 6:1018-1026.
17. Lin Y.-F., Wu M.-S., Chang C.-C., Lin S.-W., Lin J.-T., Sun Y.-J., Chen D.-S., Chow L.-P. Comparative immunoproteomics of identification and characterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol. Cell. Proteomics 2006, 5:1484-1496.
18. Marignani M., Delle Fave G., Mecarocci S., Bordi C., Angeletti S., D'Ambra G., Aprile M.R., Corleto V.D., Monarca B., Delle Fave G. High prevalence of corpus-predominant atrophic gastritis in patients with unexplained microcytic and macrocytic anemia: a prospective screening study. Am. J. Gastroenterol. 1999, 94:766-772.
19. Marshall B.J., Windsor H.M. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentaion, treatment, and prevention. Med. Clin. North Am. 2005, 89:313-344.
20. Ming S.C. Cellular and molecular pathology of gastric carcinoma and precursor lesions: a critical review. Gastric Cancer 1998, 1:31-50.
21. Mini R., Annibale B., Lahner E., Bernardini G., Figura N., Santucci A. Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin. Chem. 2006, 52:220-226.
22. Mini R., Bernardini G., Salzano A.M., Renzone G., Scaloni A., Figura N., Santucci A. Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2006, 833:63-79.
23. Mini R., Figura N., D'Ambrosio C., Braconi D., Bernardini G., Di Simplicio F., Lenzi C., Nuti R., Trabalzini L., Martelli P., Bovalini L., Scaloni A., Santucci A. Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics 2005, 5:777-787.
24. Ng E.L., Thompson S.A., Perez-Perez G.I., Kansau I., van der Ende A., Labigne A., Sung J.J., Chung S.C., Blaser M.J. Helicobacter pylori heat shock protein A: serologic responses and genetic diversity. Clin. Diagn. Lab. Immunol. 1999, 6:377-382.
25. Oh J.D., King-Bäckhed H., Giannakis M., Xu J., Fulton R.S., Fulton L.A., Cordum H.S., Wang C., Elliott G., Edwards J., Mardis E.R., Engstrand L.G., Gordon J.I. The complete genome sequence of a chronic atrophic gastritis Helicobacter pylori strain: evolution during disease progression. PNAS 2006, 103:9999-10004.
26. Park J.-W., Song J.-Y., Lee S.-G., Jun J.-S., Park J.-U., Chung M.-J., Ju J.S., Nizamutdinov D., Chang M.W., Youn H.S., Kang H.L., Baik S.C., Lee W.K., Cho M.J., Rhee K.H. Quantitative analysis of representative proteome components and clustering of Helicobacter pylori clinical strains. Helicobacter 2006, 11:533-543.
27. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108.
28. Parsonnet J. The incidence of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 1995, 9(Suppl. 2):45-51.
29. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
30. Price A.B. The Sydney System: histological division. J. Gastroenterol. Hepatol. 1991, 6:209-222.
31. Rugge M., Correa P., Dixon M.F., Hattori T., Leandro G., Lewin K., Riddell R.H., Sipponen P., Watanabe H. Gastric dysplasia: the Padova international classification. Am. J. Surg. Pathol. 2000, 24:167-176.
32. Schweinitzer T., Mizote T., Ishikawa N., Dudnik A., Inatsu S., Schreiber S., Suerbaum S., Aizawa S.-I., Josenhans C. Functional characterization and mutagenesis of the proposed behavioral sensor TlpD of Helicobacter pylori. J. Bacteriol. 2008, 190:3244-3255.
33. Svennerholm A.-M., Lundgren A. Progess in vaccine development against Helicobacter pylori. FEMS Immunol. Med. Microbiol. 2007, 50:146-156.
34. Tang R.-X., Luo D.-J., Sun A.-H., Yan J. Diversity of Helicobacter pylori isolates in expression of antigens and induction of antibodies. World J. Gastroenterol. 2008, 14:4816-4822.
35. Tomb J.-F., White O., Kerlavage A.R., Clayton R.A., Sutton G.G., Fleischmann R.D., Ketchum K.A., Klenk H.P., Gill S., Dougherty B.A., Nelson K., Quackenbush J., Zhou L., Kirkness E.F., Peterson S., Loftus B., Richardson D., Dodson R., Khalak H.G., Glodek A., McKenney K., Fitzegerald L.M., Lee N., Adams M.D., Hickey E.K., Berg D.E., Gocayne J.D., Utterback T.R., Peterson J.D., Kelley J.M., Cotton M.D., Weidman J.M., Fujii C., Bowman C., Watthey L., Wallin E., Hayes W.S., Borodovsky M., Karp P.D., Smith H.O., Fraser C.M., Venter J.C. The complete genome sequence of the gastric pathogen Helicobacter pylori. Nature 1997, 388:539-547.
36. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., Taniyama K., Sasaki N., Schlemper R.J. Helicobacter pylori and the development of gastric cancer. N. Engl. J. Med. 2001, 345:784-789.
37. Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., Lai K.C., Hu W.H., Yuen S.T., Leung S.Y., Fong D.Y., Ho J., Ching C.K., Chen J.S. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004, 291:187-194.